Event:	Central Nervous System Disease Conference
Date/Time:	Thursday, November 17, 2016
Location:	Maxim Group LLC, New York, NY

Related Posts

Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Parkinson’s Disease Dementia
July 9, 2018

Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease
July 3, 2018

Anavex participates on Brain Health panel at Bio International Conference in Boston
June 5, 2018

Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results
May 10, 2018